The PTPN22 R620W polymorphism is associated with severe bacterial infections after human leukocyte antigen geno-identical haematopoietic stem-cell transplantations

Transplantation

Volumn 85, Issue 12, 2008, Pages 1859-1862

  Azarian, Mariam ^a   Busson, Marc ^a   Rocha, Vanderson ^a   Ribaud, Patricia ^a   Peffault De Latour, Regis ^a   Bleux, Hélène ^a   Lepage, Virginia ^a   Charron, Dominique ^a   Toubert, Antoine ^a   Socié, Gérard ^a   Loiseau, Pascale ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Bacterial infection; Hematopoietic stem cell transplantation; PTPN22 polymorphism

Indexed keywords

CYCLOSPORIN; METHOTREXATE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PREDNISOLONE; HLA ANTIGEN; PTPN22 PROTEIN, HUMAN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PRIORITY JOURNAL; RELAPSE; SURVIVAL TIME; GENETIC PREDISPOSITION; GENETICS; MICROBIOLOGY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BACTERIAL INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK ASSESSMENT;

EID: 49149095185     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817729c4     Document Type: Article

References (12)

1. Gregersen PK, Lee H-S, Batliwalla F, et al. PTPN22: Setting thresholds for autoimmunity. Semin Immunol 2006; 18: 214.
2. Rocha V, Franco R, Porcher R, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100: 3908.
3. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with typeIdiabetes.Nat Genet 2004; 36: 337.
4. Fine JP, Gray RJ. A proportional hazards model for the sub distribution of a competing risk. JASA 1999; 94: 496.
5. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330.
6. Cloutier JF, Veilette A. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hematopoietic cells. EMBO J 1996; 15: 4909.
7. Cloutier JF, VeilletteA.Cooperative inhibition of T-Cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999; 189: 111.
8. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 12: 1317.
9. Socie G. Graft-versus-host disease-from the bench to the bedside? N Engl J Med 2005; 353: 1396.
10. Gomez LM, Anaja JM, Martin J. Genetic Influence of PTPN22 R620W polymorphism in tuberculosis. Hum Immunol 2005; 66: 1242.
11. Chapman SJ, Khor CC, Vannberg FO, et al. PTPN22 and invasive bacterial disease. Nat Genet 2006; 38: 499.
12. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380.